GSK kicks off trials of pioneering ‘bioelectronic’ disease treatment

The first patient has been given an implant to control rheumatoid arthritis by modifying nerve signals to the spleen
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news